ArTS Archivio della ricerca di Trieste

CONFALONIERI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.056
AS - Asia 4.222
EU - Europa 3.303
SA - Sud America 459
Continente sconosciuto - Info sul continente non disponibili 351
AF - Africa 155
OC - Oceania 37
Totale 13.583
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.827
SG - Singapore 1.340
IT - Italia 1.320
CN - Cina 871
VN - Vietnam 497
HK - Hong Kong 407
BR - Brasile 344
BD - Bangladesh 292
DE - Germania 281
KR - Corea 264
GB - Regno Unito 235
SE - Svezia 216
FR - Francia 211
NL - Olanda 196
FI - Finlandia 176
PL - Polonia 147
IN - India 121
RU - Federazione Russa 115
CA - Canada 106
IE - Irlanda 69
BG - Bulgaria 60
TR - Turchia 58
MX - Messico 57
AT - Austria 52
JP - Giappone 51
CH - Svizzera 47
MA - Marocco 47
ID - Indonesia 43
PH - Filippine 42
ES - Italia 36
IQ - Iraq 36
AR - Argentina 34
UA - Ucraina 32
AU - Australia 30
ZA - Sudafrica 28
PK - Pakistan 24
CO - Colombia 22
SA - Arabia Saudita 22
BE - Belgio 18
EC - Ecuador 17
EG - Egitto 17
UZ - Uzbekistan 16
TH - Thailandia 15
CR - Costa Rica 14
GR - Grecia 13
IR - Iran 13
TW - Taiwan 13
VE - Venezuela 13
CL - Cile 12
CZ - Repubblica Ceca 12
SN - Senegal 12
AE - Emirati Arabi Uniti 11
MY - Malesia 11
IL - Israele 10
AZ - Azerbaigian 9
NP - Nepal 9
TN - Tunisia 9
PA - Panama 8
RO - Romania 8
BY - Bielorussia 7
TT - Trinidad e Tobago 7
AO - Angola 6
DK - Danimarca 6
HN - Honduras 6
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
LK - Sri Lanka 6
LT - Lituania 6
NZ - Nuova Zelanda 6
OM - Oman 6
PT - Portogallo 6
AL - Albania 5
DZ - Algeria 5
KZ - Kazakistan 5
PE - Perù 5
PY - Paraguay 5
GT - Guatemala 4
HU - Ungheria 4
LU - Lussemburgo 4
NG - Nigeria 4
NI - Nicaragua 4
NO - Norvegia 4
PS - Palestinian Territory 4
UY - Uruguay 4
YE - Yemen 4
BB - Barbados 3
CI - Costa d'Avorio 3
EE - Estonia 3
ET - Etiopia 3
HR - Croazia 3
LY - Libia 3
MG - Madagascar 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BZ - Belize 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
KH - Cambogia 2
Totale 13.193
Salva come PNG Salva come JPEG
Città #
Singapore 737
Ashburn 702
San Jose 610
Council Bluffs 395
Hong Kong 390
Hefei 259
Seoul 259
Chandler 258
Trieste 215
Beijing 189
Los Angeles 178
Ho Chi Minh City 149
Dallas 139
Columbus 131
Boardman 120
Hanoi 117
New York 116
Santa Clara 106
Milan 105
London 104
Chicago 99
Lauterbourg 82
Helsinki 70
Lappeenranta 66
Munich 66
Zgierz 66
Frankfurt am Main 64
Dublin 58
Sofia 58
Warsaw 58
Princeton 56
Moscow 55
The Dalles 55
Rome 52
Phoenix 47
São Paulo 46
Buffalo 45
Naples 43
Turku 36
Atlanta 35
Tokyo 35
Vienna 34
Casablanca 33
Montreal 33
Amsterdam 30
Denver 30
Manchester 30
Toronto 30
Nuremberg 29
Redmond 29
Wilmington 29
Bern 25
Chennai 25
Dong Ket 25
Haiphong 25
Orem 24
Düsseldorf 23
Seattle 22
Turin 22
Houston 21
North Bergen 21
Boydton 20
Da Nang 20
Florence 20
Shanghai 20
Udine 20
Redondo Beach 19
Mexico City 18
Mumbai 18
Wroclaw 17
Bologna 16
Brussels 16
Iloilo City 16
Paris 16
Ankara 15
Baghdad 15
Berlin 15
Rio de Janeiro 15
Bremen 14
Jacksonville 14
Pordenone 14
Tashkent 14
Treviso 14
Adana 13
Barnet 13
Brasília 13
Brooklyn 13
Newark 13
San Francisco 13
Ann Arbor 12
Dakar 12
Jakarta 12
Johannesburg 12
Modena 12
San Donà di Piave 12
Stockholm 12
Thái Nguyên 12
Woodbridge 12
Genoa 11
Guangzhou 11
Totale 7.585
Salva come PNG Salva come JPEG
Nome #
Alveolar Epithelial Type II Cells 477
Deciphering loop gain complexity: a primer for understanding a pathophysiological trait of obstructive sleep apnea patients 271
Comorbidities’ Effect on IPF: Pathogenesis and Management 233
Chronic Thromboembolic Pulmonary Hypertension: An Update 229
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 225
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 225
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 221
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 216
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 215
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 212
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 210
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria 210
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 210
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 210
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 208
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 203
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon 202
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 200
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 194
The Treatment of Lung Involvement in Systemic Sclerosis 193
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 193
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 186
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 185
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 182
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 181
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 177
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 177
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 173
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 171
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis 169
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 168
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 164
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 159
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease 156
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 156
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 155
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 152
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 150
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 149
Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support 149
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 148
Host-Based Treatments for Severe COVID-19 146
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 146
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 146
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment 145
Caution When Comparing the Impact of Corticosteroids in COVID-19 145
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 144
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial 143
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 140
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and Challenges 140
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 140
Advances in Diagnostics and Management of Respiratory System Diseases 139
Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? 135
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 135
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 135
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 132
Biomarkers in Systemic Sclerosis: An Overview 131
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 130
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 129
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 128
Analyzing Sarcoidosis via Nailfold Capillaroscopy: Microvascular Insights 126
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 125
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 118
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 114
Exploring sarcoidosis via nailfold capillaroscopy: A window into the disease’s microvascular landscape 113
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study 107
Breaking barriers: holistic assessment of ability to work in patients with sarcoidosis 105
Evaluating Nailfold Capillaroscopy as a Diagnostic Tool in EGPA with Pulmonary Involvement 103
Evaluation of Nailfold Capillaroscopy as a Novel Tool in the Assessment of Eosinophilic Granulomatosis with Polyangiitis. 102
What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases? 98
Early C-reactive protein reduction predicts survival in COVID-19 severe pneumonia treated with glucocorticoids 97
Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19 97
Epithelial-Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis? 97
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? 94
Cardiac sarcoidosis recurrence post-heart transplant: A critical literature and case report 93
The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients 92
Monitoring the microcirculation in the diagnosis and follow-up of systemic sclerosis patients: Focus on pulmonary and peripheral vascular manifestations 90
Indirect evaluation of lung condition by means of LF-NMR following chest physiotherapy or ETI administration in cystic-fibrosis patients 87
Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update 79
Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials 75
Sex differences in low arousal threshold in obstructive sleep apnea 71
Retrospective Observational Study of Nintedanib in Managing Idiopathic and Progressive Pulmonary Fibrosis in Routine Practice 69
Ultra-high-resolution synchrotron phase-contrast CT enables microstructural pulmonary imaging at clinical dose levels 68
First evaluation of microvascular damage through nailfold capillaroscopy of an uncommon case of Raynaud's phenomenon in multiple sclerosis: Case report and literature review 67
Risk factor of pulmonary embolism in sarcoidosis patients: a pilot study 66
Editorial for “Diagnosis, Classification, and Monitoring of Pulmonary Diseases” 65
Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies 60
Evaluation of possible risk factor of pulmonary embolism in sarcoidosis patients 57
Existence and relevance of fulminant severe community-acquired pneumonia 57
Multinational Survey on the Symptom Approach to Diagnosis and Therapy Adopted by Physicians in the Treatment of Gastrointestinal Sarcoidosis 56
Formaldehyde vapour fixation enables multiscale phase-contrast imaging and histological validation of human-sized lungs 49
Evaluation of chronic thromboembolic pulmonary hypertension: a pilot-study 48
Investigating Fairness with FanFAIR: is Pre-processing Useful Only for Performances? 47
Trattamenti dell’ipertensione polmonare tromboembolica cronica (CTEPH): uno studio pilota 42
Mucoactive Agents in Muco-Obstructive Lung Diseases: A Critical Reappraisal of Pharmacological Effects and Clinical Outcomes 36
Effectiveness of Desensitization Therapy for Grasses and Dust Mites on Asthma Exacerbations and Respiratory Function During the Allergy Season: A Pilot Study 20
Totale 13.583
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.532
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022434 0 0 28 57 39 13 32 14 72 35 41 103
2022/2023942 79 112 94 90 78 117 29 85 119 24 75 40
2023/20241.074 70 48 81 74 108 92 223 134 39 47 96 62
2024/20252.318 59 129 173 206 187 168 137 127 249 337 234 312
2025/20267.325 603 387 521 723 569 553 945 291 816 885 605 427
2026/20271.236 428 460 348 0 0 0 0 0 0 0 0 0
Totale 13.583